Home R&D/Publications>
Latest News
See all news



IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas, Emilie Laprevotte, Christian Garbar, Aude-Marie Savoye, Hervé Curé, Corinne Mascaux, Gilles Alberici, Nathalie Bonnefoy, Jean-François Eliaou, Armand Bensussan, Jeremy Bastid, Scientific Reports, 2013.

Plasticity of Human Regulatory T Lymphocytes

Bensussan A, EuroMabNet Meeting, Menorca (Spain), 2013 Sep.

CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8+ CD39+ regulatory T cells.

Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA. European Journal Immunology. 2013 Apr 22.

Inhibition of CD39 in human bone morrow-derived mesenchymal stromal cells reduces colony formation, differentiation potential and immunosuppression

De Andrade A, Wehner R, Karbanova J, Corbeil D, Bastid J, Schmitz M, Odendahl M, Bornhäuser M, Tonn T. DGTI. 2013.

ENTPD1/CD39 is a promising therapeutic target in oncology

Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A. Oncogene. 2013 Apr.

See all events